loader image
Monday, December 22, 2025
85.1 F
McAllen
- Advertisement -

Workers Value Employer-Sponsored Health Coverage

Translate to Spanish or other 102 languages!

Employees value health coverage from employers, and it is the most important benefit an employer can offer their workers. Image for illustration purposes
Employees value health coverage from employers, and it is the most important benefit an employer can offer their workers. Image for illustration purposes

Mega Doctor News

- Advertisement -

‌US CHAMBER OF COMMERCE

Employees value health coverage from employers, and it is the most important benefit an employer can offer their workers.

Why it matters: The findings from a survey sponsored by Protecting Americans Coverage Together – a coalition that includes the Chamber – reaffirm the high degree of importance workers have in employer-sponsored health insurance (ESI). Policymakers should do more to support and strengthen it.

- Advertisement -

By the numbers:

·  96% said health insurance was either “Extremely important” (83%) or “Very important” (13%) to them

·  93% said they were satisfied with their insurance

·  87% said their plans are affordabl

- Advertisement -


Be smart: 89% of Americans prefer to get health coverage through an employer than through other means.

·  And: 81% said they would rather receive their coverage from an employer than a government-provided health plan

Our take: “Employees value their employer-sponsored health coverage,” said Katie Mahoney, Chamber Vice President of Health Policy. “ESI is working for the people with access to it, and the goal of policymakers should be to strengthen and bolster the system to help more people.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

From Patient to Hero: Isaac Garza Delivers 2,089 Smiles This Holiday Season

Mega Doctor News For Isaac Garza, it’s better to give than to receive during the...

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.
- Advertisement -
×